Abstract
Tivozanib is a tyrosine kinase inhibitor that targets all vascular endothelial growth factor receptors (VEGFRs), causing inhibition of angiogenesis. I......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
